Literature DB >> 33051955

Readmission and mortality among heart failure patients with history of hypertension in a statewide database.

Michail Giakoumis1, Davit Sargsyan1, John B Kostis1, Javier Cabrera2, Sanketkumar Dalwadi1, William J Kostis1.   

Abstract

Objective was to examine the temporal trends in readmission and mortality of heart failure (HF) patients with history of hypertension. This study includes 51 141 patients with history of hypertension who were discharged with a first diagnosis of HF between January 1, 2000, and December 31, 2014. Data were obtained from the Myocardial Infarction Data Acquisition System (MIDAS), a statewide database of all hospitalizations for cardiovascular (CV) disease in New Jersey. The temporal trends of mortality, rates of HF-specific readmission, and all-cause readmissions up to 1 year after discharge were examined using multivariable logistic regression. The difference in all-cause mortality at 3 years between patients who were readmitted compared to those who were not readmitted at 1 year was examined. The number of patients with history of hypertension and HF remained unchanged during the study period. Male gender, black race, comorbidities, and admission to non-teaching hospitals were predictors of HF readmission and CV mortality (P < .05 for all). Readmission rate for any cause increased during the study period (P < .001) while rates of HF readmissions and mortality remained relatively unchanged. Patients that had been readmitted within a year exhibited a significantly higher 3-year mortality (P < .001). CV mortality among HF patients with history of hypertension did not change significantly between 2000 and 2014, while the rates of all-cause readmission increased. Patients who were readmitted had higher 3-year mortality (P < .001) than those who were not.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  heart failure; hypertension; population‐based study; readmissions

Mesh:

Year:  2020        PMID: 33051955      PMCID: PMC8029945          DOI: 10.1111/jch.13918

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  45 in total

Review 1.  A systematic review and meta-analysis on the association between quality of hospital care and readmission rates in patients with heart failure.

Authors:  Claudia Fischer; Ewout W Steyerberg; Gregg C Fonarow; Theodore G Ganiats; Hester F Lingsma
Journal:  Am Heart J       Date:  2015-07-18       Impact factor: 4.749

Review 2.  Comparative effectiveness of transitional care services in patients discharged from the hospital with heart failure: a systematic review and network meta-analysis.

Authors:  Harriette G C Van Spall; Tahseen Rahman; Oliver Mytton; Chinthanie Ramasundarahettige; Quazi Ibrahim; Conrad Kabali; Michiel Coppens; R Brian Haynes; Stuart Connolly
Journal:  Eur J Heart Fail       Date:  2017-02-24       Impact factor: 15.534

3.  EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot).

Authors:  Aldo P Maggioni; Ulf Dahlström; Gerasimos Filippatos; Ovidiu Chioncel; Marisa Crespo Leiro; Jaroslaw Drozdz; Friedrich Fruhwald; Lars Gullestad; Damien Logeart; Gianna Fabbri; Renato Urso; Marco Metra; John Parissis; Hans Persson; Piotr Ponikowski; Mathias Rauchhaus; Adriaan A Voors; Olav Wendelboe Nielsen; Faiez Zannad; Luigi Tavazzi
Journal:  Eur J Heart Fail       Date:  2013-03-28       Impact factor: 15.534

4.  Heart failure hospitalization: An important prognostic factor for heart failure re-admission and mortality.

Authors:  Ana Ruigómez; Alexander Michel; Mar Martín-Pérez; Luis A García Rodríguez
Journal:  Int J Cardiol       Date:  2016-06-23       Impact factor: 4.164

5.  Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

Authors:  Kirkwood F Adams; Gregg C Fonarow; Charles L Emerman; Thierry H LeJemtel; Maria Rosa Costanzo; William T Abraham; Robert L Berkowitz; Marie Galvao; Darlene P Horton
Journal:  Am Heart J       Date:  2005-02       Impact factor: 4.749

6.  All-Payer Analysis of Heart Failure Hospitalization 30-Day Readmission: Comorbidities Matter.

Authors:  Jonathan D Davis; Margaret A Olsen; Kerry Bommarito; Shane J LaRue; Mohammed Saeed; Michael W Rich; Justin M Vader
Journal:  Am J Med       Date:  2016-08-31       Impact factor: 4.965

7.  Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study.

Authors:  David H Smith; Micah L Thorp; Jerry H Gurwitz; David D McManus; Robert J Goldberg; Larry A Allen; Grace Hsu; Sue Hee Sung; David J Magid; Alan S Go
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-05-17

8.  Hospital strategies associated with 30-day readmission rates for patients with heart failure.

Authors:  Elizabeth H Bradley; Leslie Curry; Leora I Horwitz; Heather Sipsma; Yongfei Wang; Mary Norine Walsh; Don Goldmann; Neal White; Ileana L Piña; Harlan M Krumholz
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-07

9.  Sex differences in the management and long-term outcome of acute myocardial infarction. A statewide study. MIDAS Study Group. Myocardial Infarction Data Acquisition System.

Authors:  J B Kostis; A C Wilson; K O'Dowd; P Gregory; S Chelton; N M Cosgrove; A Chirala; T Cui
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

10.  Evaluation of 30-Day Hospital Readmission and Mortality Rates Using Regression-Discontinuity Framework.

Authors:  Rohan Khera; Yongfei Wang; Khurram Nasir; Zhenqiu Lin; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2019-07-16       Impact factor: 24.094

View more
  1 in total

1.  Readmission and mortality among heart failure patients with history of hypertension in a statewide database.

Authors:  Michail Giakoumis; Davit Sargsyan; John B Kostis; Javier Cabrera; Sanketkumar Dalwadi; William J Kostis
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-07-07       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.